241 - 252 of 7730 results

The Clinical Progression of Heart Failure: Can You Recognize the Signs of Worsening Disease?

Industry Podcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

The clinical course of heart failure is progressive and often involves periods of disease worsening that can be challenging to identify for both patients and their health care providers.1-4 In this episode, featuring cardiologist Dr Lee Goldberg of the University of Pennsylvania, we will discuss key aspects of the clinical assessment of heart failure worsening and progression in the outpatient setting and emphasize the importance of optimizing guideline-directed medical therapy in patients with worsening heart failure as well as in those with stable disease.


0.25 CME CREDIT

Lifestyle management has proven effective for addressing modifiable health risks, but can be challenging for patients to implement and maintain. This session will focus on wellness coaching as an important component of healthy living, both for patients and providers. Participants will learn about the benefits of engaging patients in health and wellness coaching, and will discuss strategies for incorporating this practice into their own patient care setting(s).


0.25 CME CREDIT

Listen to this podcast for a concise summary of the latest clinical practice guidelines for identifying glycemic targets and managing T2DM in various patient populations including, older adults, individuals with increased cardiac or renal risk, and those at risk for hypoglycemic events.


0.25 CME CREDIT

Bacterial vaginosis—especially recurrent BV—can be an ordeal for patients and their healthcare providers. Listen as Dr. Martin Quan provides concise and up-to-date information on the pathophysiology, diagnosis, and management of BV.


0.25 CME CREDIT

This podcast will review the harms of tobacco products and discuss the growing popularity and dangers of non-cigarette tobacco products. Faculty will discuss the vaping associated lung injury and outline approaches that PCPs can use to help their patients with tobacco cessation.


0.25 CME CREDIT

This podcast provides a succinct overview of what you need to know to manage osteoporosis confidently, including selecting candidates for treatment, monitoring patients, and the benefits and potential adverse effects of osteoporosis pharmacotherapy.


0.25 CME CREDIT

This podcast will review updates to the clinical guidelines for the management of chronic obstructive pulmonary disease, tailored specifically to primary care. The discussion will include the diagnosis and basic management of COPD, when to consider escalating and deescalating treatment regimens, and when to consider expert referral.


0.5 CME CREDIT

In the twelfth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the most recent information on COVID-19 vaccines and testing. This episode will review the mechanisms and clinical trial status of each vaccine currently in development and discuss recent literature comparing different sampling techniques in COVID-19 testing. Lastly, faculty will explore how pre-test probability is important to understanding test accuracy. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/16/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the eleventh episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent publications and issues related to COVID-19 including the retraction of two major trials on hydroxychloroquine from Lancet and NEJM, the results of a trial investigating hydroxychloroquine as post-exposure prophylaxis for COVID-19, and the results of a study investigating transmission and viral shedding of COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/10/2020 and they are subject to change as new information is published.


FAQ for the Pharmacotherapy of Alcohol and Opioid Use Disorders

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.Guest: Petros Levounis, MD, MA

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.


1 CME CREDIT

This initiative aims to increase understanding among cardiologists about adjunctive LDL-C-lowering therapies and their potential role in reducing residual ASCVD risk. During this series, national lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, and explore novel targets and treatment pathways. It is expected to improve cardiologists’ management of patients with ‘tough-to-treat’ cholesterol according to the 2018 American Heart Association (AHA)/American College of Cardiology (ACC)/Multi-society Cholesterol Guidelines. Learners will have the opportunity to gain practical clinical perspectives during expert case study discussions. The patient scenarios will discuss how new treatment options may fit into the current therapeutic landscape.


0.5 CME CREDIT

Get your questions answered by expert faculty in Psychiatry. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7th 2020, and they are subject to change as new information is published.